Neurocrine Biosciences Inc

US BANCORP \DE\ NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/30/2026

Shares

3,432

Value ($000)

487

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/30/2026	487	0.0%	3,432	12/31/2025
2025 Q3	11/12/2025	493	0.0%	3,513	9/30/2025
2025 Q2	7/24/2025	516	0.0%	4,102	6/30/2025
2025 Q1	5/8/2025	412	0.0%	3,729	3/31/2025
2024 Q4	2/5/2025	570	0.0%	4,175	12/31/2024
2024 Q3	10/28/2024	445	0.0%	3,864	9/30/2024
2024 Q2	8/7/2024	767	0.0%	5,573	6/30/2024
2024 Q1	5/8/2024	684	0.0%	4,959	3/31/2024
2023 Q4	2/9/2024	775	0.0%	5,885	12/31/2023
2023 Q3	11/3/2023	603	0.0%	5,363	9/30/2023
2023 Q2	8/10/2023	1,034	0.0%	10,969	6/30/2023
2023 Q1	5/9/2023	2,393	0.0%	23,638	3/31/2023
2022 Q4	2/13/2023	2,740	0.0%	22,942	12/31/2022
2022 Q3	10/27/2022	3,100	0.0%	29,171	9/30/2022
2022 Q2	8/1/2022	3,043	0.0%	31,211	6/30/2022
2022 Q1	5/11/2022	2,917	0.0%	31,115	3/31/2022
2021 Q4	2/11/2022	1,839	0.0%	21,591	12/31/2021
2021 Q3	11/10/2021	2,918	0.0%	30,421	9/30/2021
2021 Q2	8/5/2021	3,001	0.0%	30,834	6/30/2021
2021 Q1	4/28/2021	2,829	0.0%	29,094	3/31/2021
2020 Q4	2/4/2021	2,082	0.0%	21,728	12/31/2020
2020 Q3	11/10/2020	1,748	0.0%	18,179	9/30/2020
2020 Q2	8/7/2020	546	0.0%	4,475	6/30/2020
2020 Q1	5/13/2020	330	0.0%	3,820	3/31/2020
2019 Q4	2/4/2020	410	0.0%	3,809	12/31/2019
2014 Q1	5/14/2014	3	0.0%	200	3/31/2014
2013 Q4	2/13/2014	2	0.0%	200	12/31/2013